These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 21785099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation.
    Yamakado K, Nakatsuka A, Takaki H, Sakurai H, Isaji S, Yamamoto N, Shiraki K, Takeda K.
    AJR Am J Roentgenol; 2010 Feb; 194(2):530-5. PubMed ID: 20093620
    [Abstract] [Full Text] [Related]

  • 3. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG, Yoon CJ, Jeong SH, Kim JW, Lee SH, Lee KH, Kim YH.
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K.
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [Abstract] [Full Text] [Related]

  • 5. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
    Fujimori M, Takaki H, Nakatsuka A, Uraki J, Yamanaka T, Hasegawa T, Shiraki K, Takei Y, Sakuma H, Yamakado K.
    J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
    [Abstract] [Full Text] [Related]

  • 6. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K.
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO, Kim SK, Son BH, Yoo CH, Hong HP, Cho YK, Kim BI.
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [Abstract] [Full Text] [Related]

  • 9. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A, Yamakado K, Takeda K, Takei Y.
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM, Lee PH, Shau WY, Ho MC, Wu YM, Hu RH.
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [Abstract] [Full Text] [Related]

  • 12. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ, Yang JY, Lü MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP.
    Zhonghua Yi Xue Za Zhi; 2011 Aug 23; 91(31):2190-4. PubMed ID: 22094036
    [Abstract] [Full Text] [Related]

  • 13. Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.
    Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, Tazawa H, Chayama K, Asahara T, Ohdan H.
    J Surg Oncol; 2011 Jul 01; 104(1):3-9. PubMed ID: 21656523
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K.
    J Gastroenterol Hepatol; 2010 Mar 01; 25(3):597-604. PubMed ID: 20074153
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS.
    Radiology; 2012 Feb 01; 262(2):689-700. PubMed ID: 22157201
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ, Huang WS, Zhou B, Chen JW, Cai MY, Qian JS, Huang MS, Shan H, Zhu KS.
    Zhonghua Yi Xue Za Zhi; 2013 Sep 03; 93(33):2627-30. PubMed ID: 24360041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.